These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 24442582)
41. A single-chain TALEN architecture for genome engineering. Sun N; Zhao H Mol Biosyst; 2014 Mar; 10(3):446-53. PubMed ID: 24336919 [TBL] [Abstract][Full Text] [Related]
42. Comparison of TALEN scaffolds in Xenopus tropicalis. Nakajima K; Yaoita Y Biol Open; 2013 Dec; 2(12):1364-70. PubMed ID: 24285709 [TBL] [Abstract][Full Text] [Related]
43. Optimized TAL effector nucleases (TALENs) for use in treatment of sickle cell disease. Sun N; Liang J; Abil Z; Zhao H Mol Biosyst; 2012 Apr; 8(4):1255-63. PubMed ID: 22301904 [TBL] [Abstract][Full Text] [Related]
44. Current Overview of TALEN Construction Systems. Sakuma T; Yamamoto T Methods Mol Biol; 2017; 1630():25-36. PubMed ID: 28643246 [TBL] [Abstract][Full Text] [Related]
45. A TALE of two nucleases: gene targeting for the masses? Clark KJ; Voytas DF; Ekker SC Zebrafish; 2011 Sep; 8(3):147-9. PubMed ID: 21929364 [TBL] [Abstract][Full Text] [Related]
46. T-CAST: An optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds. Rhiel M; Geiger K; Andrieux G; Rositzka J; Boerries M; Cathomen T; Cornu TI Front Genome Ed; 2023; 5():1130736. PubMed ID: 36890979 [TBL] [Abstract][Full Text] [Related]
47. Highly efficient targeted mutagenesis in mice using TALENs. Panda SK; Wefers B; Ortiz O; Floss T; Schmid B; Haass C; Wurst W; Kühn R Genetics; 2013 Nov; 195(3):703-13. PubMed ID: 23979585 [TBL] [Abstract][Full Text] [Related]
48. An efficient TALEN mutagenesis system in rice. Chen K; Shan Q; Gao C Methods; 2014 Aug; 69(1):2-8. PubMed ID: 24556552 [TBL] [Abstract][Full Text] [Related]
53. TALEN- and CRISPR/Cas9-Mediated Gene Editing in Human Pluripotent Stem Cells Using Lipid-Based Transfection. Hendriks WT; Jiang X; Daheron L; Cowan CA Curr Protoc Stem Cell Biol; 2015 Aug; 34():5B.3.1-5B.3.25. PubMed ID: 26237572 [TBL] [Abstract][Full Text] [Related]
54. A robust TALENs system for highly efficient mammalian genome editing. Feng Y; Zhang S; Huang X Sci Rep; 2014 Jan; 4():3632. PubMed ID: 24407151 [TBL] [Abstract][Full Text] [Related]
55. Methods for targeted mutagenesis in zebrafish using TALENs. Hwang WY; Peterson RT; Yeh JR Methods; 2014 Aug; 69(1):76-84. PubMed ID: 24747922 [TBL] [Abstract][Full Text] [Related]
56. Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. Liu J; Gaj T; Patterson JT; Sirk SJ; Barbas CF PLoS One; 2014; 9(1):e85755. PubMed ID: 24465685 [TBL] [Abstract][Full Text] [Related]
57. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Holkers M; Maggio I; Liu J; Janssen JM; Miselli F; Mussolino C; Recchia A; Cathomen T; Gonçalves MA Nucleic Acids Res; 2013 Mar; 41(5):e63. PubMed ID: 23275534 [TBL] [Abstract][Full Text] [Related]
58. The I-TevI nuclease and linker domains contribute to the specificity of monomeric TALENs. Kleinstiver BP; Wang L; Wolfs JM; Kolaczyk T; McDowell B; Wang X; Schild-Poulter C; Bogdanove AJ; Edgell DR G3 (Bethesda); 2014 Apr; 4(6):1155-65. PubMed ID: 24739648 [TBL] [Abstract][Full Text] [Related]
59. An optimized TALEN application for mutagenesis and screening in Lee HB; Sebo ZL; Peng Y; Guo Y Cell Logist; 2015; 5(1):e1023423. PubMed ID: 26196022 [TBL] [Abstract][Full Text] [Related]